AMANDA LEWIS: Open Payments
NPI 1861639395 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 25 payments from 15 companies in 2025. Trend: 2023 $361 · 2024 $739 · 2025 $506
Food & beverage: $506
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 6 | $116 |
| Tandem Diabetes Care, Inc. | 2 | $51 |
| BETA BIONICS, INC. | 2 | $41 |
| CeQur Corporation | 1 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Ascendis Pharma Endocrinology Inc | 2 | $36 |
| Amgen Inc. | 2 | $33 |
| ABBVIE INC. | 1 | $23 |
| Baxter Healthcare | 1 | $22 |
| Chiesi USA, Inc. | 1 | $20 |
Products named: RECORLEV, t:slim X2 Insulin Pump with Control-IQ, iLet Bionic Pancreas, CeQur Simplicity, Kerendia, Yorvipath, PERCLOT, MYCAPSSA.
Industry payments across OK — which companies pay providers there.
